[Epidermodysplasia verruciformis (EV) after bone marrow transplantation for the treatment of severe combined immunodeficiency: a model to understand the specific immunodeficiency of EV?].
Descamps
V
V
Clinique des Maladies cutanées, Hôpital Saint-Louis, Paris.
Blanchet-Bardon
C
C
Petit
A
A
Baccard
M
M
Fisher
A
A
Dubertret
L
L
D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002648:Child; D002678:Chimera / Q000276:immunology; D004819:Epidermodysplasia Verruciformis / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D006801:Humans; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D009000:Monocytes / Q000276:immunology; D016511:Severe Combined Immunodeficiency / Q000601:surgery*; D014184:Transplantation, Homologous
Epidermodysplasie verruciforme (EV) après greffe de moelle pour traitement d'un déficit immunitaire combiné sévère: un modèle pour comprendre le déficit immunitaire spécifique de l'EV?